Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 198,521 | 163,502 | 71,835 | 70,217 | 67,135 |
Marketable Securities | N/A | N/A | 22,393 | 16,003 | 6,035 |
Receivables | 69,259 | 45,551 | 23,914 | 20,236 | 16,267 |
Inventories | 23,468 | 33,121 | N/A | 209 | N/A |
Income taxes - deferred | N/A | N/A | N/A | 2,028 | 874 |
Other current assets | 17 | 295 | 295 | 673 | 673 |
TOTAL | $307,232 | $251,360 | $121,848 | $113,353 | $92,914 |
Non-Current Assets | |||||
PPE Net | 6,216 | 6,393 | 763 | 1,156 | 1,540 |
Investments And Advances | 5,495 | 0 | 13,540 | 7,219 | 14,408 |
Intangibles | 201,156 | 191,252 | 151 | 6,438 | 7,415 |
Other Non-Current Assets | 752 | 8,176 | 5,272 | 8,711 | 11,519 |
TOTAL | $213,619 | $205,821 | $19,726 | $23,524 | $34,882 |
Total Assets | $520,851 | $457,181 | $141,574 | $136,877 | $127,796 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 9,190 | 11,213 | 4,143 | 7,614 | 5,496 |
Accrued Expenses | 12,389 | 10,886 | 8,467 | 5,682 | 10,595 |
Other current liabilities | 2,304 | 19,762 | 9,618 | 358 | 1,003 |
TOTAL | $32,351 | $88,127 | $33,810 | $42,612 | $40,071 |
Non-Current Liabilities | |||||
Long Term Debt | 290,516 | 213,277 | 17,578 | 25,828 | 33,722 |
Deferred Revenues | 1,315 | 676 | 2,051 | 1,365 | 3,700 |
Other Non-Current Liabilities | 8,791 | 15,743 | 1,936 | 1,233 | 1,253 |
TOTAL | $321,401 | $282,605 | $25,452 | $35,296 | $44,695 |
Total Liabilities | $353,752 | $370,732 | $59,262 | $77,908 | $84,766 |
Shareholders' Equity | |||||
Shares Outstanding, K | 46,457 | 45,539 | 44,901 | 43,998 | 41,970 |
Common Shares | 464 | 455 | 446 | 432 | 420 |
Retained earnings | 38,126 | 19,639 | -13,732 | -26,860 | -34,100 |
Other shareholders' equity | 54,258 | 13,143 | 13,952 | 15,288 | 16,189 |
TOTAL | $167,099 | $86,449 | $82,312 | $58,969 | $43,030 |
Total Liabilities And Equity | $520,851 | $457,181 | $141,574 | $136,877 | $127,796 |